3 August 2015Insurance

A firm hand on innovation

The unpredictability of the pharmaceutical and life sciences sector, given its infrequent nature and reliance on innovation, can result in devastating claims for insurers. However, insurers must continue to strive to smooth out the volatility and make these risks more stable.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Arch brakes harder: NWP down 7% on rising retro, primary book pruning

29 July 2026 Primary insurance underwriting margin slides toward break-even as cat losses jump in Q2.

Lancashire grows H1 profit but misses out on growth for increased margin

29 July 2026 ‘Planned reduction in inwards property retrocession’ stalls insurance revenue.

Gallagher announces passing of lead independent director David Johnson

29 July 2026 Long-serving board member remembered after more than two decades of service.

More articles

Aon maintains 5% organic revenue growth for third straight quarter

Arch brakes harder: NWP down 7% on rising retro, primary book pruning

Lancashire grows H1 profit but misses out on growth for increased margin

Gallagher announces passing of lead independent director David Johnson

‘Insurance doesn’t need another chatbot’ as Cowbell rings in AI underwriting platform

Intact grows 4% Q2, but suffers margin blow out on select lines

Re/insurance past its peak, but danger is still two seasons away

Hanover hits record Q2 net income, commercial underwriting slips

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze